Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Ketamine Infusions for Chronic Pain
NCT04123652Phase 4Completed
- Sponsor
- Allevio Pain Management
- Start
- Nov 2017
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine, ketamine in neuropathic pain, fibromyalgia (FM), sponsored by Allevio Pain Management. Started Nov 2017; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineketamine
03
Conditions
neuropathic painfibromyalgia (FM)
Beyond the preview
Go deeper on NCT04123652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04123652.